Biomarkers may yield information relevant to disease outcome on three progressive levels: (i) as measurable endpoints of damage to proteins/amino acids, oxidised lipids, oxidised DNA bases, (ii) as functional markers of, for example, blood flow, platelet aggregation, or cognitive function, and (iii) as endpoints related to specific disease
Vitamin C cn tng kh nng hp th Glutathione, ti u ha hiu qu lm trng da v chng lo ha
[DOI] [PubMed] [Google Scholar] 95.Dieker JW, van der Vlag J, Berden JH
If you want to explore this broader wellness lens, the Healthy Aging collection is a natural place to start
Our study provides a base for the screening and validation of true tyrosinase inhibitors for treating tyrosinase linked disorders and diseases
Annu Rev Immunol